Brought to you by 
Allergan buys CNS company Naurex for $560mm
01 Jun 2021
Executive Summary
Allergan PLC acquired Naurex Inc., a closely held neurological drug developer, for $560mm in cash--$460mm at closing and $100mm by January 2016. In addition, Allergan may pay R&D and sales earn-outs.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Technologies
- Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Payment Includes Cash for Equity
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Allergan buys CNS company Naurex for $560mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice